---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-070496"
form_type: "8-K"
ticker: "EMED"
cik: "0001715819"
company_name: "Electromedical Technologies, Inc"
filed_at: "2022-06-13T23:59:59+00:00"
generated_at: "2026-06-25T02:25:00.897210+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Electromedical Technologies appoints Lee Benson as independent director

## Summary
- Lee Benson, age 61, appointed independent director effective June 7, 2022.
- Compensation: $5,000 monthly salary payable in common shares.
- Benson founded Able Aerospace, grew it from 3 to 500+ employees, sold to Textron Aviation.
- No family relationships or related transactions with the company disclosed.

## SEC filing metadata
- accession: 0001104659-22-070496
- form_type: 8-K
- ticker: EMED
- cik: 0001715819
- company_name: Electromedical Technologies, Inc
- filed_at: 2022-06-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1715819/000110465922070496/0001104659-22-070496-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1715819/000110465922070496/tm2218335d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-070496
- JSON: https://secwatch.observer/filing/0001104659-22-070496.json
- Plain text: https://secwatch.observer/filing/0001104659-22-070496.txt

## Key facts
- Executive change
  Lee Benson was appointed as independent director at Electromedical Technologies, Inc.
  - Action: appointed
  - Role: independent director
  source text: On June 7, 2022, the registrant appointed Lee Benson, age 61, as an independent director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1715819/000110465922070496/0001104659-22-070496-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.